NCT03566407View on ClinicalTrials.gov

Blood and Stool Molecular Biomarkers Longitudinal Detection Study in Crohn's Disease (CD) Patients

NATerminatedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

May 4, 2018

Primary Completion Date

March 29, 2019

Study Completion Date

March 29, 2019

Conditions
Crohn's Disease
Interventions
PROCEDURE

Colonoscopy

Colonoscopy will be required for all subjects at 6 months - Visit 3.

Trial Locations (5)

30309

Atlanta Gastroenterology Associates, LLC, Atlanta

53226

Medical College of Wisconsin, Milwaukee

90033

University of Southern California, Los Angeles

93003

Ventura Clinical Trials, LLC., Ventura

06518

Medical Research Center of Connecticut, LLC, Hamden

Sponsors
All Listed Sponsors
lead

Prometheus Laboratories

INDUSTRY

NCT03566407 - Blood and Stool Molecular Biomarkers Longitudinal Detection Study in Crohn's Disease (CD) Patients | Biotech Hunter | Biotech Hunter